As of 2025-03-19, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 30.93 USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.08 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 40.1%.
The range of the Relative Valuation is 21.98 - 51.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 26.3x | 19.4x |
| Forward P/E multiples | 15.6x - 36.5x | 25.4x |
| Fair Price | 21.98 - 51.29 | 30.93 |
| Upside | -0.5% - 132.3% | 40.1% |
| Date | P/E |
| 2025-03-18 | 16.36 |
| 2025-03-17 | 16.16 |
| 2025-03-14 | 15.58 |
| 2025-03-13 | 15.47 |
| 2025-03-12 | 15.71 |
| 2025-03-11 | 15.53 |
| 2025-03-10 | 15.32 |
| 2025-03-07 | 16.27 |
| 2025-03-06 | 16.06 |
| 2025-03-05 | 16.22 |
| 2025-03-04 | 16.38 |
| 2025-03-03 | 16.54 |
| 2025-02-28 | 16.96 |
| 2025-02-27 | 16.05 |
| 2025-02-26 | 15.25 |
| 2025-02-25 | 15.41 |
| 2025-02-24 | 15.75 |
| 2025-02-21 | 16.02 |
| 2025-02-20 | 16.34 |
| 2025-02-19 | 16.70 |
| 2025-02-18 | 16.99 |
| 2025-02-14 | 17.24 |
| 2025-02-13 | 17.24 |
| 2025-02-12 | 16.82 |
| 2025-02-11 | 16.73 |
| 2025-02-10 | 16.87 |
| 2025-02-07 | 16.97 |
| 2025-02-06 | 17.09 |
| 2025-02-05 | 17.34 |
| 2025-02-04 | 17.11 |
| 2025-02-03 | 16.76 |
| 2025-01-31 | 16.72 |
| 2025-01-30 | 17.18 |
| 2025-01-29 | 17.76 |
| 2025-01-28 | 16.93 |
| 2025-01-27 | 16.82 |
| 2025-01-24 | 16.71 |
| 2025-01-23 | 16.68 |
| 2025-01-22 | 16.95 |
| 2025-01-21 | 16.98 |
| 2025-01-17 | 16.88 |
| 2025-01-16 | 16.79 |
| 2025-01-15 | 17.09 |
| 2025-01-14 | 16.44 |
| 2025-01-13 | 16.46 |
| 2025-01-10 | 16.24 |
| 2025-01-08 | 16.90 |
| 2025-01-07 | 14.47 |
| 2025-01-06 | 14.96 |
| 2025-01-03 | 15.79 |